November 21, 2026

Ruhal wants fake drugs traders fixed

Health minister has sought pharmaceutical industry's cooperation to tame fake drug traders.

bdnews24.com News Service

bdnews24.com

Published : 28 Mar 2011, 05:58 PM

Updated : 10 Aug 2022, 04:33 PM

Dhaka, March 28 (bdnews24.com) – Health minister has sought cooperation of pharmaceutical industry to rein in 'notorious' traders who supply adulterated drugs in the market. A F M Ruhal Haque on Monday said the process of upgrading drug testing labs would be finalised soon, so as to make it of WHO standards. "It will help increase the export growth," the minister said at the 40th annual general meeting of Bangladesh Association of Pharmaceutical Industries (BAPI) in the capital. "But we want to rein in 'notorious' traders," the minister said, adding the health ministry alone could not achieve the task. "BAPI has to cooperate…" Although there is no data available as to the specific quantity of adulterated drug sale in the country, law enforcing agencies seize huge amounts of such drugs every year across Bangladesh. Speaking on the occasion, BAPI president Salman F Rahman said local pharmaceutical production met 97 percent of the national demand. "We have also potential to export huge quantities of drugs…in fact, sky is the limit, if we can win confidence of importers," he said suggesting a stronger drug administration in the country. "Building confidence among importers not only depends on the quality of drugs, but also the professionalism of the regulators," he said. Director General of the Directorate of Drug Administration Abul Kalam Azad said they would be able to recruit enough manpower within two-three months to run the directorate in proper and effective manner. BAPI secretary general Abdul Muktadir said the pharmaceutical sector's domestic sales figure had crossed $1 billion in 2010 — a growth of 23 percent over 2009. "At this rate, our local market can double in the next three-four years," he said. The export market of generic medicines is about $100 billion and the market is fast growing because of patent expiries and healthcare cost saving initiatives by several European governments and Japan. He also stressed on tapping Bangladesh's potential as a supplier of generic drugs. "If we can supply compliant products, it is possible to export generic products worth $10 billion," Muktadir said. Aggressive marketing by local companies, increased public health awareness and investments in the sector have helped cross the local sales mark, experts believe. bdnews24.com/nih/nir/2330h
Related Stories